期刊
ONCOLOGY-NEW YORK
卷 33, 期 3, 页码 91-100出版社
UBM MEDICA
关键词
-
类别
资金
- NCI NIH HHS [P50 CA221747] Funding Source: Medline
- NINDS NIH HHS [R00 NS082381, K99 NS082381, R01 NS097851, F32 NS073366] Funding Source: Medline
Glioblastoma is an aggressive primary tumor of the central nervous system. This review will focus on clinical developments and management of newly diagnosed disease, including a discussion about the incorporation of molecular features into the classification of glioblastoma. Such advances will continue to shape our thinking about the disease and how to best manage it. With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumortreating fields will be presented. Pivotal studies defining our current standard of care will be highlighted, as will key ongoing trials that may influence our management of glioblastoma in the near future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据